Therefore, this study aims to explore whether SLBZD can play a role in promoting the efficacy of PD-1 inhibitors in the treatment of colorectal cancer by influencing the intestinal microenvironment and Tumor microenvironment. The gene discussed is PDCD1; the disease is colorectal cancer.